US2011318789A1PendingUtilityA1
Prokaryotic dna repair ligases
Est. expiryAug 12, 2023(expired)· nominal 20-yr term from priority
C12N 9/93C12Q 1/6816
35
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to the cloning and characterisation of a prokaryotic DNA repair ligase, which is shown to possess a range of activities that allow the ligation and repair of non-compatible DNA ends and double strand breaks (DSBs). The enzyme has a range of applications in the manipulation and cloning of nucleic acids.
Claims
exact text as granted — not AI-modified1 . A method of modifying a nucleic acid molecule comprising;
contacting the nucleic acid molecule with a prokaryotic DNA repair ligase polypeptide.
2 . A method according to claim 1 wherein the prokaryotic DNA repair ligase polypeptide comprises one or more of: a primase domain, a nuclease domain, and a ligase domain, said one or more domains sharing greater than 20% sequence identity with the corresponding domain sequence of Mt-Lig (CAB08492).
3 . A method according to claim 1 wherein the prokaryotic DNA repair ligase polypeptide shares greater than 20% sequence identity with the sequence of Mt-Lig (CAB08492).
4 . A method according to claim 1 wherein the prokaryotic DNA repair ligase polypeptide is Mt-Lig (CAB08492) or a variant or allele thereof.
5 . A method according to claim 1 wherein the nucleic acid molecule and the Mt-Lig polypeptide are contacted in the presence of a prokaryotic Ku polypeptide.
6 . A method according to claim 5 wherein the prokaryotic Ku polypeptide shares greater than 20% sequence identity with the sequence of Mt-Ku (CAB08491).
7 . A method according to claim 6 wherein the prokaryotic Ku polypeptide is Mt-Ku (CAB08491) or an allele or variant thereof.
8 . A method of ligating nucleic acid molecule ends comprising;
contacting a first nucleic acid end and a second nucleic acid end with an prokaryotic DNA repair ligase polypeptide, wherein said first and said second nucleic acid ends are non-compatible.
9 . A method according to claim 8 wherein said first and said second nucleic acid ends comprise non-complementary overhang regions.
10 . A method according to claim 8 wherein the first end is on a first nucleic acid molecule and the second end is on a second nucleic acid molecule.
11 . A method according to claim 10 wherein the first and second nucleic acid molecules are DNA.
12 . A method according to claim 10 wherein the first nucleic acid molecule is DNA and the second nucleic acid molecule is RNA.
13 . A method according to claim 8 wherein the first and second ends are on the same nucleic acid molecule.
14 . A method according to claim 8 comprising isolating and/or purifying the ligated nucleic acid molecule.
15 . A method of labelling a nucleic acid molecule comprising;
contacting a nucleic molecule having a first terminus with an prokaryotic DNA repair ligase polypeptide in the presence of labelled nucleotides.
16 . A method according to claim 15 wherein the nucleotides are NTPs.
17 . A method according to claim 15 wherein the nucleotides are dNTPs.
18 . A method of filling in a single stranded gap in a double stranded nucleic acid molecule comprising;
contacting a double stranded nucleic acid molecule having a single stranded region with an prokaryotic DNA repair ligase polypeptide.
19 . A method according to claim 18 wherein said nucleic acid molecule and said prokaryotic DNA repair ligase polypeptide are contacted in the presence of NTPs.
20 . A method according to claim 18 wherein said nucleic acid molecule and said prokaryotic DNA repair ligase polypeptide are contacted in the presence of dNTPs.
21 . A method of removing a single stranded overhang from the end of a nucleic acid molecule comprising;
contacting said nucleic acid molecule with a prokaryotic DNA repair ligase polypeptide
22 . A method according to claim 21 wherein the prokaryotic DNA repair ligase polypeptide is an Mt-Lig polypeptide.
23 . A method according to claim 21 wherein said nucleic acid molecule is contacted in the presence of Mg 2+ or Mn 2+ .
24 . A method of producing an RNA molecule comprising;
contacting a prokaryotic DNA repair ligase polypeptide and a template DNA strand in the presence of NTPs.
25 . A method according to claim 24 wherein prokaryotic DNA repair ligase and template DNA are contacted in the presence of a primer oligonucleotide.
26 . A method of producing a DNA molecule comprising;
contacting A prokaryotic DNA repair ligase polypeptide and a nucleic acid template in the presence of dNTPs and a primer oligonucleotide.
27 . A method according to claim 26 wherein the nucleic acid template is an RNA template.
28 . A method according to claim 26 wherein the nucleic acid template is an DNA template.
29 . A method according to claim 8 wherein the prokaryotic DNA repair ligase polypeptide comprises one or more of: a primase domain, a nuclease domain, and a ligase domain, said one or more domains sharing greater than 20% sequence identity with the corresponding domain sequence of Mt-Lig (CAB08492).
30 . A method according to claim 8 wherein the prokaryotic DNA repair ligase polypeptide shares greater than 20% sequence identity with the sequence of Mt-Lig (CAB08492).
31 . A method according to claim 8 wherein the prokaryotic DNA repair ligase polypeptide is Mt-Lig (CAB08492) or a variant or allele thereof.
32 . A method according to claim 8 wherein the nucleic acid molecule and the Mt-Lig polypeptide are contacted in the presence of a prokaryotic Ku polypeptide.
33 . A method according to claim 32 wherein the prokaryotic Ku polypeptide shares greater than 20% sequence identity with the sequence of Mt-Ku (CAB08491).
34 . A method according to claim 32 wherein the prokaryotic Ku polypeptide is Mt-Ku (CAB08491) or an allele or variant thereof.
35 . A kit comprising an isolated Mt-Lig polypeptide for use in a method according to claim 1 .
36 . A kit according to claim 35 comprising an isolated Mt-Ku polypeptide.
37 . A kit according to claim 35 comprising dNTPs.
38 . A kit according to claim 35 comprising NTPs.
39 . A kit according to claim 35 comprising one or more of buffers, stabilisers and excipients.
40 . A method of producing a prokaryotic DNA repair polypeptide comprising;
(a) causing expression from nucleic acid which encodes a prokaryotic DNA repair polypeptide in a suitable expression system to produce the polypeptide recombinantly; and, testing the recombinantly produced polypeptide for prokaryotic DNA repair activity.
41 . A method according to claim 40 wherein the recombinantly produced polypeptide is tested for one or more of: non-complementary end ligation activity, DNA dependent RNA primase activity, 3′-5′ exonuclease activity, DNA and RNA dependent DNA polymerase activity, DNA dependent RNA polymerase activity, ATP dependent DNA and RNA ligase activity and DNA terminal transferase activity.
42 . A method according to claim 39 wherein the prokaryotic DNA repair polypeptide is an Mt-Lig polypeptide or an allele or variant thereof.
43 . A method according to claim 40 comprising purifying said recombinantly produced polypeptide.Join the waitlist — get patent alerts
Track US2011318789A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.